Searchable abstracts of presentations at key conferences in endocrinology

ea0035p952 | Steroid metabolism and action | ECE2014

A hypercoagulable state associated with intravenous pulse methylprednisolone (MP) therapy in patients with Graves' orbitopathy

Rutkowska Beata , Miskiewicz Piotr , Trautsolt-Jeziorska Katarzyna , Pirko-Kotela Katarzyna , Milczarek-Banach Justyna , Wolczanska Natalia , Jelenska Magdalena , Glowczynska Renata , Bednarczuk Tomasz

Introduction: Chronic exposure to glucocorticoid excess, either endogenous or exogenous, is associated with a hypercoagulable state and a high thromboembolism risk. The underlying mechanism of this phenomenon is still unclear. Clinical studies have indicated various abnormalities of procoagulant, anti-coagulant and fibrynolytic factors, e.g.: alterations of clotting factors (F), plasminogen activator inhibitor (PAI-1), plasminogen, antithrombin. Moreover, other consequences of...

ea0035p1103 | Thyroid Cancer | ECE2014

Single nucleotide polymorphisms associated with papillary thyroid cancer

Kula Dorota , Michal Kalemba , Daria Handkiewicz-Junak , Zbigniew Puch , Malgorzata Kowalska , Monika Kowal , Tomasz Tyszkiewicz , Renata Cyplinska , Joanna Polanska , Barbara Jarzab

Papillary thyroid cancer (PTC) is well known family occurring cancer disease. It is estimated, that ~5% of differentiated thyroid cancers (where PTC is the most frequent) are hereditary. Susceptibility genes are poorly known, however, recently some SNPs located on chromosome 9 in FOXE1 locus (rs965513) and on chromosome 14 (rs944289) close to NKX2-1 locus have been confirmed to be associated with PTC in different populations.The aim of our study was to a...

ea0035p1152 | Thyroid Cancer | ECE2014

Gene expression signature associated with BRAFV600E mutation in human papillary thyroid carcinoma based on transgenic mouse model

Rusinek Dagmara , Swierniak Michal , Chmielik Ewa , Kowal Monika , Kowalska Malgorzata , Czarniecka Agnieszka , Przeorek Cezary , Cyplinska Renata , Jarzab Michal , Widlak Wieslawa , Jarzab Barbara

Objectives: Recent studies on BRAFV600E mutation, known as initiating event in papillary thyroid carcinoma (PTC) and related to more aggressive clinical course of the disease, revealed its significant influence on gene expression profile suggesting that BRAF(+)PTCs represent a molecular subtype of PTC. However, the human material disables distinction of possible molecular causes of cancer from its effects, unlike the mouse model. The main goal of our project was to find genes ...

ea0070aep10 | Adrenal and Cardiovascular Endocrinology | ECE2020

Cortisol rhythm in patients with adrenal insufficiency switched from conventional glucocorticoids to dual release hydrocortisone: Impact on metabolic profile

Simeoli Chiara , Iacono Marina , Ferrigno Rosario , Negri Mariarosaria , Pivonello Claudia , Simona Auriemma Renata , De Martino Maria Cristina , Colao Annamaria , Pivonello Rosario

Background: Several evidences suggested that conventional glucocorticoids (CGCs) used as replacement treatment in adrenal insufficiency (AI) are inadequate to mimic physiological cortisol circadian rhythm (CCR), and that CCR disruption, represented by non-physiological pattern of peaks and troughs and elevated evening GC levels, might be responsible for the increased metabolic and, consequently, cardiovascular risk. It has been demonstrated that once daily dual-release-hydroco...

ea0070aep341 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Anti-Lipogenic effects of cabergoline: A molecular study on white adipocytes

Negri Mariarosaria , Pivonello Claudia , Amatrudo Feliciana , Gentile Annalisa , Montò Tatiana , Patalano Roberta , Simeoli Chiara , Ferrigno Rosario , Simona Auriemma Renata , Colao Annamaria , Pivonello Rosario

Obesity is caused by an imbalance between dietary energy intake and expenditure. The expression of dopamine receptors (DRs) in human adipocytes has been already demonstrated. Moreover, the effects of cabergoline, a dopamine agonist, on body weight and glucose homeostasis in obese subjects without hyperprolactinemia has already been reported. The current study investigates the effects of cabergoline on lipid accumulation and on adipogenic factors expression to better define the...

ea0070aep391 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Arginine metabolism and gut microbiota changes in pediatric patients with type 1 diabetes

Aghajanova Elena , Melkonyan Arthur , Alchujyan Nina , Gayane Bayburdyan , Hovhannisyan Margarita , Navasardyan Lusine , Markosyan Renata , Kalantaryan Lusine , Issa Vrej , Arakelyan Lusine , Gevorgyan Zara

Introduction: Incidence of type 1 diabetes mellitus (T1DM) is rising steadily around the globe, including Armenia. It is one of the most common autoimmune and metabolic disorders in pediatric population, resulting from autoimmune destruction of pancreatic β-cells leading to insulin deficiency. Gut microbiota (GM) is reportedly involved in the pathogenesis of T1DM likely by influencing the immune response with the help of arginine-metabolizing enzymes. Arginase i...

ea0070ep275 | General Endocrinology | ECE2020

Endocrinopathy in patients with glomerulonephritis undergoing renal biopsy – single center observation

Gala-Bladzinska Agnieszka , Orłowska-Florek Renata , Sztembis Joanna , Rałowska Katarzyna , Opalińska Anna , Nawrocka Julia , Pich Aleksandra , Wojton Karolina

Introduction: Endocrine disorders and kidney diseases can coexist. Some of these have a common pathophysiological background. Strategies for treating endocrinopathy or glomerulonephritis (GN) may affect the function of the endocrine system and kidney.Aim: The study was aimed to assess the correlation of kidney biopsy results performed in people with suspected GN with thyroid function, metabolic syndrome and diabetes occurrence.Mate...

ea0032p276 | Clinical case reports - Thyroid / Others | ECE2013

Barraquer-Simons syndrome

Baracho Maria Fatima , Santos Maria Goreti , Amaral Beatriz , Carmo Raissa , Rafael Renata , Melo Luciana , Araujo Maria Augusta , Santos Gemma , Oliveira-Filho Antonio , Nunes Adriana

The Barraquer-Simons syndrome is a rare form of partial symmetric lipodystrophy with involvement of the face and upper body, of unknown cause, characterized by loss of subcutaneous fat in the face and started stretching for the upper body.Case report: Female patient, 26 years old, presenting morphologic change in facies, chest, upper limbs, lower limbs and abdomen since she was 10 years old. Last year, she has increased weight at 30%, with apparent muscl...

ea0032p830 | Pituitary–Basic (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Mutations of SOX2 gene: a novel heterozygous mutation and impact on congenital hypopituitarism

Auriemma Renata S , Macchiaroli Annamaria , Kelberman Daniel , Faienza Maria F , Corona Rosalia , Mariano Iolanda , Giangiobbe Sara , Galdiero Mariano , Pivonello Rosario , Colao Annamaria , Gasperi Maurizio

Introduction: Anophthalmia/microphthalmia is a rare developmental craniofacial defect often associated to congenital hypopituitarism with GH deficiency and hypogonadism. SOX2 gene plays a key role in embryonic development regulation and heterozygous mutations of this gene, reported only in 14 patients to date, have been associated to anophthalmia/microphthalmia and congenital hypopituitarism in uo to 10% of cases. Therefore, the study of the SOX2 gene can be clinically useful ...

ea0032p866 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Effects of short (12 months) and long (60 months) term treatment with cabergoline on metabolic syndrome and visceral adiposity index in patients with hyperprolactinemia

Auriemma Renata S , Granieri Luciana , Perone Ylenia , Galdiero Mariano , Grasso Ludovica , Simeoli Chiara , Pivonello Claudia , Gasperi Maurizio , Giordano Carla , Colao Annamaria , Pivonello Rosario

Introduction: Hyperprolactinemia is reportedly associated with an impaired metabolic profile, particularly in patients with concomitant hypogonadism. The current study aimed at investigating the effects of short (12 months) and long (60 months) treatment with cabergoline (CAB) on metabolic complications, metabolic syndrome (MS) prevalence and visceral adiposity index (VAI) in hyperprolactinemic patients.Patients and methods: Seventy-one patients (51 F, 2...